Compounds > artemisinin
Page last updated: 2024-08-25

artemisinin and Cancer of Prostate

artemisinin has been researched along with Cancer of Prostate in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aivaliotis, VI; Firestone, GL; Steely, AM; Sundar, SN; Willoughby, JA1
Efferth, T; Michaelsen, FW; Saeed, ME; Schwarzkopf, J1
Futaki, S; Gallis, B; Goodlett, DR; Lacoste, E; Lai, H; Nakase, I; Oh, S; Sasaki, T; Singh, NP; Takatani-Nakase, T; Tanaka, S1
Cheung, M; Firestone, GL; Modiano, J; Sundar, SN; Tin, AS; Willoughby, JA1
Gallis, BM; Gong, Y; Goodlett, DR; Lacoste, E; Lai, H; Lu, H; Sasaki, T; Yang, Y1

Other Studies

5 other study(ies) available for artemisinin and Cancer of Prostate

ArticleYear
Artemisinin disrupts androgen responsiveness of human prostate cancer cells by stimulating the 26S proteasome-mediated degradation of the androgen receptor protein.
    Anti-cancer drugs, 2017, Volume: 28, Issue:9

    Topics: Artemisinins; Cell Line, Tumor; Chromones; Down-Regulation; Enzyme Inhibitors; Humans; Kallikreins; Male; Morpholines; Mutation; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Prostate-Specific Antigen; Prostatic Neoplasms; Proteasome Endopeptidase Complex; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-mdm2; Receptors, Androgen; Transcription, Genetic; Ubiquitination

2017
Activity of Artemisia annua and artemisinin derivatives, in prostate carcinoma.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2015, Dec-15, Volume: 22, Issue:14

    Topics: Aged, 80 and over; Artemisia annua; Artemisinins; Artesunate; Biomarkers, Tumor; Bone Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Immunohistochemistry; Male; Neoplasm Metastasis; Prostate-Specific Antigen; Prostatic Neoplasms

2015
Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of apoptosis.
    Cancer letters, 2009, Feb-18, Volume: 274, Issue:2

    Topics: Apoptosis; Artemisinins; Blotting, Western; Cell Line, Tumor; Circular Dichroism; Humans; Male; Prostatic Neoplasms; Receptors, Transferrin; RNA, Small Interfering; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Transferrin

2009
Artemisinin blocks prostate cancer growth and cell cycle progression by disrupting Sp1 interactions with the cyclin-dependent kinase-4 (CDK4) promoter and inhibiting CDK4 gene expression.
    The Journal of biological chemistry, 2009, Jan-23, Volume: 284, Issue:4

    Topics: Artemisinins; Binding Sites; Cell Cycle; Cell Line, Tumor; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Gene Expression Regulation, Neoplastic; Humans; Male; Mutagenesis, Site-Directed; Phosphorylation; Promoter Regions, Genetic; Prostatic Neoplasms; Protein Binding; Retinoblastoma Protein; Sp1 Transcription Factor; Transcription, Genetic

2009
Effects of transferrin conjugates of artemisinin and artemisinin dimer on breast cancer cell lines.
    Anticancer research, 2013, Volume: 33, Issue:1

    Topics: Apoptosis; Artemisinins; beta Catenin; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Female; Humans; Inhibitor of Apoptosis Proteins; Male; Prostatic Neoplasms; Protein Multimerization; Proto-Oncogene Proteins c-myc; Receptor, ErbB-2; Survivin; Transferrin; Wnt Signaling Pathway

2013